New patent for Astellas drug XTANDI
Annual Drug Patent Expirations for XTANDI Xtandi is a drug marketed by Astellas and is included in two NDAs. It […]
Patent Added
New patent for Glaxo Grp drug ADVAIR HFA
Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in
New patent for Astrazeneca Ab drug FARXIGA
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA.
New patent for Glaxosmithkline drug ARNUITY ELLIPTA
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA.
New patent for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
New patent for Slayback Pharma drug VIVIMUSTA
Annual Drug Patent Expirations for VIVIMUSTA Vivimusta is a drug marketed by Slayback Pharma Llc and is included in one
New patent for Amgen Inc drug LUMAKRAS
Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA.
New patent for Catalyst Pharms drug AGAMREE
Annual Drug Patent Expirations for AGAMREE Agamree is a drug marketed by Catalyst Pharms and is included in one NDA.
New patent for Glaxosmithkline drug VENTOLIN HFA
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA.
New patent for Glaxosmithkline drug VENTOLIN HFA Read Post »
New patent for Ferring drug FIRMAGON
Annual Drug Patent Expirations for FIRMAGON Firmagon is a drug marketed by Ferring and is included in one NDA. It
